{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T07:19:06Z","timestamp":1777792746802,"version":"3.51.4"},"reference-count":30,"publisher":"Japan Neurosurgical Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.2176\/nmccrj.cr.2020-0151","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T22:08:07Z","timestamp":1624399687000},"page":"301-307","source":"Crossref","is-referenced-by-count":6,"title":["Malignant Progression of an IDH Mutant Brainstem Glioma in Adult"],"prefix":"10.2176","volume":"8","author":[{"given":"Kenshi","family":"SANO","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Yamagata University Faculty of Medicine, Yamagata, Yamagata, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichiro","family":"MATSUDA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Yamagata University Faculty of Medicine, Yamagata, Yamagata, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"KAWANAMI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Yamagata University Faculty of Medicine, Yamagata, Yamagata, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonehiro","family":"KANEMURA","sequence":"additional","affiliation":[{"name":"Department of Biomedical Research and Innovation, Institute for Clinical Research, National Hospital Organization Osaka National Hospital, Osaka, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rintaro","family":"OHE","sequence":"additional","affiliation":[{"name":"Department of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata, Yamagata, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiko","family":"SONODA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Yamagata University Faculty of Medicine, Yamagata, Yamagata, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"971","reference":[{"key":"1","unstructured":"1) Louis DN, Ohgaki H, Wiestler OD, Cavenee WK: <i>WHO Classification of Tumours of the Central Nervous System<\/i>. Revised 4th edition. IARC, France, 2016"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Eisele SC, Reardon DA: Adult brainstem gliomas. <i>Cancer<\/i> 15: 2799\u20132809, 2016","DOI":"10.1002\/cncr.29920"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Kloosterhof NK, Bralten LB, Dubbink HJ, et al.: Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma? <i>Lancet Oncol<\/i> 12: 83\u201391, 2011","DOI":"10.1016\/S1470-2045(10)70053-X"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Theeler BJ, Ellezam B, Melguizo-Gavilanes I, et al.: Adult brainstem gliomas: correlation of clinical and molecular features. <i>J Neurol Sci<\/i> 353: 92\u201397, 2015","DOI":"10.1016\/j.jns.2015.04.014"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Guillamo JS, Monjour A, Taillandier L, et al.: Brainstem gliomas in adults: prognostic factors and classification. <i>Brain<\/i> 124: 2528\u20132539, 2001","DOI":"10.1093\/brain\/124.12.2528"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Cahill DP, Levine KK, Betensky RA, et al.: Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment. <i>Clin Cancer Res<\/i> 13: 2038\u20132045, 2007","DOI":"10.1158\/1078-0432.CCR-06-2149"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Felsberg J, Thon N, Eigenbrod S, et al.: Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas. <i>Int J Cancer<\/i> 129: 659\u2013670, 2011","DOI":"10.1002\/ijc.26083"},{"key":"8","unstructured":"8) Arita H, Yamasaki K, Matsushita Y, et al.: A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas. <i>Acta Neuropathol Commun<\/i> 4: 79, 2016"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Sasaki T, Fukai J, Kodama Y, et al.: Characteristics and outcomes of elderly patients with diffuse gliomas: a multi-institutional cohort study by Kansai Molecular Diagnosis Network for CNS Tumors. <i>J Neurooncol<\/i> 140: 329\u2013339, 2018","DOI":"10.1007\/s11060-018-2957-7"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Ostrom QT, Gittleman H, Truitt G, et al.: CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015. <i>Neuro Oncol<\/i> 20: iv1\u2013iv86, 2018","DOI":"10.1093\/neuonc\/noy131"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Warren KE, Killian K, Suuriniemi M, Wang Y, Quezado M, Meltzer PS: Genomic aberrations in pediatric diffuse intrinsic pontine gliomas. <i>Neuro Oncol<\/i> 14: 326\u2013332, 2012","DOI":"10.1093\/neuonc\/nor190"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kesari S, Kim RS, Markos V, Drappatz J, Wen PY, Pruitt AA: Prognostic factors in adult brainstem gliomas: a multicenter, retrospective analysis of 101 cases. <i>J Neurooncol<\/i> 88: 175\u2013183, 2008","DOI":"10.1007\/s11060-008-9545-1"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Jackson S, Patay Z, Howarth R, et al.: Clinico-radiologic characteristics of long-term survivors of diffuse intrinsic pontine glioma. <i>J Neurooncol<\/i> 114: 339\u2013344, 2013","DOI":"10.1007\/s11060-013-1189-0"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Buczkowicz P, Bartels U, Bouffet E, Becher O, Hawkins C: Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications. <i>Acta Neuropathol<\/i> 128: 573\u2013581, 2014","DOI":"10.1007\/s00401-014-1319-6"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Gielen GH, Gessi M, Hammes J, Kramm CM, Waha A, Pietsch T: H3F3A K27M mutation in pediatric CNS tumors: a marker for diffuse high-grade astrocytomas. <i>Am J Clin Pathol<\/i> 139: 345\u2013349, 2013","DOI":"10.1309\/AJCPABOHBC33FVMO"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Khuong-Quang DA, Buczkowicz P, Rakopoulos P, et al.: K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. <i>Acta Neuropathol<\/i> 124: 439\u2013447, 2012","DOI":"10.1007\/s00401-012-0998-0"},{"key":"17","unstructured":"17) Sturm D, Witt H, Hovestadt V, et al.: Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. <i>Cancer Cell<\/i> 22: 425\u2013437, 2012"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Chiang JC, Ellison DW: Molecular pathology of paediatric central nervous system tumours. <i>J Pathol<\/i> 241: 159\u2013172, 2017","DOI":"10.1002\/path.4813"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Daoud EV, Rajaram V, Cai C, et al.: Adult brainstem gliomas with H3K27M mutation: radiology, pathology, and prognosis. <i>J Neuropathol Exp Neurol<\/i> 77: 302\u2013311, 2018","DOI":"10.1093\/jnen\/nly006"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Ellezam B, Theeler BJ, Walbert T, et al.: Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas. <i>Acta Neuropathol<\/i> 124: 449\u2013451, 2012","DOI":"10.1007\/s00401-012-1011-7"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Liu XY, Gerges N, Korshunov A, et al.: Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1\/IDH2 and TP53 mutations. <i>Acta Neuropathol<\/i> 124: 615\u2013625, 2012","DOI":"10.1007\/s00401-012-1031-3"},{"key":"22","unstructured":"22) Schwartzentruber J, Korshunov A, Liu XY, et al.: Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. <i>Nature<\/i> 482: 226\u2013231, 2012"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Solomon DA, Wood MD, Tihan T, et al.: Diffuse midline gliomas with histone H3-K27M mutation: a series of 47 cases assessing the spectrum of morphologic variation and associated genetic alterations. <i>Brain Pathol<\/i> 26: 569\u2013580, 2016","DOI":"10.1111\/bpa.12336"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Reyes-Botero G, Giry M, Mokhtari K, et al.: Molecular analysis of diffuse intrinsic brainstem gliomas in adults. <i>J Neurooncol<\/i> 116: 405\u2013411, 2014","DOI":"10.1007\/s11060-013-1312-2"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Zhang L, Chen LH, Wan H, et al.: Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas. <i>Nat Genet<\/i> 46: 726\u2013730, 2014","DOI":"10.1038\/ng.2995"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Javadi SA, Hartmann C, Walter GF, Banan R, Samii A: IDH1 mutation in brain stem glioma: case report and review of literature. <i>Asian J Neurosurg<\/i> 13: 414\u2013417, 2018","DOI":"10.4103\/1793-5482.228540"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Ogura R, Tsukamoto Y, Natsumeda M, et al.: Immunohistochemical profiles of IDH1, MGMT and P53: practical significance for prognostication of patients with diffuse gliomas. <i>Neuropathology<\/i> 35: 324\u2013335, 2015","DOI":"10.1111\/neup.12196"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Hegi ME, Diserens AC, Gorlia T, et al.: MGMT gene silencing and benefit from temozolomide in glioblastoma. <i>N Engl J Med<\/i> 352: 997\u20131003, 2005","DOI":"10.1056\/NEJMoa043331"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Hu J, Western S, Kesari S: Brainstem glioma in adults. <i>Front Oncol<\/i> 6: 180, 2016","DOI":"10.3389\/fonc.2016.00180"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Aziz Y, Knepper L, Lerberman F, et al.: Brainstem anaplastic astrocytoma, IDH-mutant, WHO grade III presenting with multiple cranial nerve palsies and diffuse neuroaxis leptomeningeal involvement. <i>Neurology<\/i> 94: 4885, 2020","DOI":"10.1212\/WNL.94.15_supplement.4885"}],"container-title":["NMC Case Report Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/8\/1\/8_cr.2020-0151\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T11:37:25Z","timestamp":1725277045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/8\/1\/8_cr.2020-0151\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2176\/nmccrj.cr.2020-0151","relation":{},"ISSN":["2188-4226"],"issn-type":[{"value":"2188-4226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}